These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 21635208)

  • 21. Predictive QSAR modeling of HIV reverse transcriptase inhibitor TIBO derivatives.
    Mandal AS; Roy K
    Eur J Med Chem; 2009 Apr; 44(4):1509-24. PubMed ID: 18760864
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Inhibitory mode of indole-2-carboxamide derivatives against HLGPa: molecular docking and 3D-QSAR analyses.
    Liu G; Zhang Z; Luo X; Shen J; Liu H; Shen X; Chen K; Jiang H
    Bioorg Med Chem; 2004 Aug; 12(15):4147-57. PubMed ID: 15246091
    [TBL] [Abstract][Full Text] [Related]  

  • 23. QSAR modeling of matrix metalloproteinase inhibition by N-hydroxy-alpha-phenylsulfonylacetamide derivatives.
    Fernández M; Caballero J
    Bioorg Med Chem; 2007 Sep; 15(18):6298-310. PubMed ID: 17590339
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A self-adaptive genetic algorithm-artificial neural network algorithm with leave-one-out cross validation for descriptor selection in QSAR study.
    Wu J; Mei J; Wen S; Liao S; Chen J; Shen Y
    J Comput Chem; 2010 Jul; 31(10):1956-68. PubMed ID: 20512843
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Predictive QSAR modeling of phosphodiesterase 4 inhibitors.
    Kovalishyn V; Tanchuk V; Charochkina L; Semenuta I; Prokopenko V
    J Mol Graph Model; 2012 Feb; 32():32-8. PubMed ID: 22023934
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Molecular structural characteristics as determinants of estrogen receptor selectivity.
    Agatonovic-Kustrin S; Turner JV; Glass BD
    J Pharm Biomed Anal; 2008 Sep; 48(2):369-75. PubMed ID: 18511229
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Quantum chemical QSAR models to distinguish between inhibitory activities of sulfonamides against human carbonic anhydrases I and II and bovine IV isozymes.
    Deeb O; Goodarzi M; Khadikar PV
    Chem Biol Drug Des; 2012 Apr; 79(4):514-22. PubMed ID: 22181786
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Molecular modeling and 3D-QSAR studies on the interaction mechanism of tripeptidyl thrombin inhibitors with human alpha-thrombin.
    Jiang H; Chen K; Tang Y; Chen J; Li Q; Wang Q; Ji R
    J Med Chem; 1997 Sep; 40(19):3085-90. PubMed ID: 9301672
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A novel serine protease inhibition motif involving a multi-centered short hydrogen bonding network at the active site.
    Katz BA; Elrod K; Luong C; Rice MJ; Mackman RL; Sprengeler PA; Spencer J; Hataye J; Janc J; Link J; Litvak J; Rai R; Rice K; Sideris S; Verner E; Young W
    J Mol Biol; 2001 Apr; 307(5):1451-86. PubMed ID: 11292354
    [TBL] [Abstract][Full Text] [Related]  

  • 30. QSAR modeling of AT1 receptor antagonists using ANN.
    Su Q; Zhou L
    J Mol Model; 2006 Sep; 12(6):869-75. PubMed ID: 16541251
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Exploration of human serum albumin binding sites by docking and molecular dynamics flexible ligand-protein interactions.
    Deeb O; Rosales-Hernández MC; Gómez-Castro C; Garduño-Juárez R; Correa-Basurto J
    Biopolymers; 2010 Feb; 93(2):161-70. PubMed ID: 19785033
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Structural bioinformatics and QSAR analysis applied to the acetylcholinesterase and bispyridinium aldoximes.
    Mager PP; Weber A
    Drug Des Discov; 2003; 18(4):127-50. PubMed ID: 15553925
    [TBL] [Abstract][Full Text] [Related]  

  • 33. 3D-QSAR and molecular docking studies on benzothiazole derivatives as Candida albicans N-myristoyltransferase inhibitors.
    Sheng C; Zhu J; Zhang W; Zhang M; Ji H; Song Y; Xu H; Yao J; Miao Z; Zhou Y; Zhu J; Lü J
    Eur J Med Chem; 2007 Apr; 42(4):477-86. PubMed ID: 17349719
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Study of the Differential Activity of Thrombin Inhibitors Using Docking, QSAR, Molecular Dynamics, and MM-GBSA.
    Mena-Ulecia K; Tiznado W; Caballero J
    PLoS One; 2015; 10(11):e0142774. PubMed ID: 26599107
    [TBL] [Abstract][Full Text] [Related]  

  • 35. 3D-QSAR and receptor modeling of tyrosine kinase inhibitors with flexible atom receptor model (FLARM).
    Peng T; Pei J; Zhou J
    J Chem Inf Comput Sci; 2003; 43(1):298-303. PubMed ID: 12546565
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparative binding energy analysis considering multiple receptors: a step toward 3D-QSAR models for multiple targets.
    Murcia M; Morreale A; Ortiz AR
    J Med Chem; 2006 Oct; 49(21):6241-53. PubMed ID: 17034130
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Compounds binding to the S2-S3 pockets of thrombin.
    Nilsson M; Hämäläinen M; Ivarsson M; Gottfries J; Xue Y; Hansson S; Isaksson R; Fex T
    J Med Chem; 2009 May; 52(9):2708-15. PubMed ID: 19371038
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Non-linear quantitative structure-activity relationship for adenine derivatives as competitive inhibitors of adenosine deaminase.
    Sadat Hayatshahi SH; Abdolmaleki P; Safarian S; Khajeh K
    Biochem Biophys Res Commun; 2005 Dec; 338(2):1137-42. PubMed ID: 16256072
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Molecular docking and QSAR study on steroidal compounds as aromatase inhibitors.
    Dai Y; Wang Q; Zhang X; Jia S; Zheng H; Feng D; Yu P
    Eur J Med Chem; 2010 Dec; 45(12):5612-20. PubMed ID: 20926163
    [TBL] [Abstract][Full Text] [Related]  

  • 40. In silico Prediction of Inhibitory Constant of Thrombin Inhibitors Using Machine Learning.
    Zhao J; Zhu L; Zhou W; Yin L; Wang Y; Fan Y; Chen Y; Liu H
    Comb Chem High Throughput Screen; 2018; 21(9):662-669. PubMed ID: 30569853
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.